|
|
|
| home > ict > Spring 2020 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
|
 |
| |
|
|
|
|
Comparator Sourcing in Clinical Studies (Part Two of Two)
In the conclusion of this two-part article, the evolving pharma market is addressed,
along with how certain phenomena in the commercial sector have shaped the drugsourcing methodologies utilised in the research sector today
Toby Watkins at CTSS
|
|
|
|
UK Data Protection in Post-Marketing Pharmacovigilance
New guidance notes prepared by PIPA intend to help companies performing post-marketing pharmacovilance in the UK meet their data protection obligations
Avile Grey at PIPA
|
|
|
|
Search and Rescue
ICT speaks to Leslie Jones at WuXi Clinical about the reasons behind why some clinical trials need rescuing, how to select the right rescue CRO, and how to ensure
a successful transition
|
|
|
|
|
The Long Road to eSource
Since the introduction of electronic diaries in the early 2000s, eSource has provided an excellent opportunity to not only streamline clinical research, but increase data quality and trustworthiness
Rebecca D Kush at Elligo Health Research
|
|
|
|
Managing Trial Data Collection for Success
From EDC to DDC, BYOD, and beyond, clinical trial data collection is an evolving field that must now step up to make virtual trials and the future of clinical data management a reality
Ed Seguine at Clinical Ink
|
|
|
|
|
|
Turning Over the Right Stones: Rethinking the Recruitment Process
Patient enrolment is often approached broadly with paid media campaigns and social outreach, but should a more streamlined method be adopted to ensure a successful
recruitment process?
Tyler Bye at WCG ThreeWire
|
|
|
|
Targeted Online Marketing in Patient Recruitment
In a world brimming with connectivity, patient recruitment efforts can be optimised by a targeted online marketing approach, utilising technology-based platforms
Bethany Bray at AutoCruitment
|
|
|
|
Study-Life Balance: Re-envisioning the Patient Experience
A new clinical trial construct leverages patient-centric solutions in response to today’s empowered healthcare consumer, who has expectations for an enhanced healthcare experience
Jessica Kim at BBK Worldwide
|
|
|
|
A Digital Approach to Enrolment
ICT met with Barbara D’haene and Nathalie Niclaus at Akcelis (recently acquired by Pivotal) to talk on the current make-up of patient enrolment and how digital technologies can be used to better target patient populations
|
|
|
|
|
|
Is the Pandemic a Time for Inflection or Reflection?
While many clinical trials are paused for the pandemic, can we find ways to reframe the clinical research landscape for a brighter healthcare future?
Sarah Beeby at Clinithink
|
|
|
|
While the World Waits
In response to the urgent need for a vaccine and treatments for COVID-19, researchers are, at the time of writing, running approximately 500 clinical trials, and counting, on a number of antivirals and vaccines
Cindy Dukes at ICON
|
|
|
|
From Zero to Sixty: Why Yesterday’s eClinical Trial Horizon Is Today’s Reality
Signant Health discusses the possibilities for trials post-pandemic. After a digital revolution in the way we conduct research, why would we want to go back?
Bill Byrom and Barb Enger at Signant Health
|
|
|
|
Pushing ‘Go’ Again on Clinical Trials in a Post-COVID-19 World
COVID-19 has caused a revolution in the world of clinical research, with the industry turning to home health, direct-to-patient, and telemedicine. What of those already planning for patients returning to site?
Andy Thurstan at Illingworth Research Group
|
|
|
|
Accelerating COVID-19 and Other Vaccine Trials Without Sacrificing Data Quality
How can a reusable eDiary platform benefit sponsors, sites, and study participants with the challenges involved in vaccine clinical trials?
Matt McCarty and Nadeeka Dias at ERT
|
|
|
|
|
Navigating ECG Cardiac Safety Requirements
To prevent the risk of induced arrhythmias in cardiac drug development, it is important for developers and biotech companies to adhere to ECG safety requirements in early stage research
Jay W Mason and Cassandra Erato at Spaulding Clinical Research
|
|
|
|
Integration of Cardiac Endpoints
Within R&D and drug development, there is growing insight and direction related to the integration of ECG and blood pressure, as well as cardiac imaging endpoints in oncology clinic trials
Jeff Heilbraun at Bioclinica
|
|
|
|
|
|
Transformational Real-World Applications
Momentum and vision around identification of medicinal products must be maintained in 2020 so approved, standardised medicines data become the de facto means of wide scale information exchange and delivery
Remco Munnik at Iperion
|
|
|
|
The Future Awaits Us
On the back of the release of Trilogy Writing & Consulting’s second special edition magazine, EPC sits down with Barry Drees to expand on
medical writing trends in the industry
|
|
|
|
Role of Comparators in Clinical Trial Designs
It is important to analyse the role of comparators in different trial designs, but which methodology should be applied for choosing the most appropriate comparators?
Dr Vanessa Dekou at Clinical Services International
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer
Grupo NotreDame Intermédica (GNDI) is the largest healthcare operator in
Brazil, with 6.4 million members. Founded in 1968, it is a pioneer in
preventive medicine. GNDI has a wide offer, comprising 29 hospitals, 88
clinical centers, 23 autonomous emergency rooms, 15 preventive medicine
centers and 2 health centers exclusively dedicated to the over-fifties.
More info >> |
|
 |
White Papers |
 |
|
Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices
Phillips-Medisize
An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed
clinical trials can all benefit from these novel, next-generation technologies.
More info >> |
|
|
